Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Probing T-Cell Response in a Hypoxic Pancreatic Tumour Microenvironment using TRACER
FY 2018-19
Summary
Pancreatic cancer is set to surpass breast cancer as the third leading cause of cancer deaths in Canada. Currently, only 7% of patients with pancreatic cancer will survive five years after diagnosis. The disease is often diagnosed too late for surgery, and it is generally resistant to chemotherapy and radiation. As such, new treatment options are desperately needed. Immunotherapy - treatments which recruit a patient's immune system to eliminate cancer cells - has been successful for some cancers but has fallen short in pancreatic cancer. This is partly because pancreatic cancer actively suppresses the immune system, preventing it from killing cancer cells. Investigating the interaction between the immune system and cancer cells using traditional 2D or living animal models has not yielded effective ways to solve this problem. Now, a 3D platform developed by our lab called "Tumour Roll for Analysis of Cellular Environment" - TRACER - is creating new opportunities to study these interactions.
TRACER is an engineered 3D tumour model. Cells are grown on a paper strip wrapped around a metal cylinder to create a tumour in a dish that is similar to what would be in a patient. Unlike in a patient, TRACER can be unrolled to look inside the tumour to examine cell interactions up-close. This allows us to understand why immune cells are not functioning properly. Using TRACER, we will create tumours using patients' cells to investigate cellular interactions and identify molecules in the environment that affect the immune system. We will then engineer immune cells to function in the tumour environment and kill cancer cells. In knowing which engineered cells are successful, we can highlight the gene and protein targets which may be important to enhancing immunotherapy in pancreatic cancer and pass these targets along to those developing new drugs. In doing so, we will potentially create treatments that improve the quality of life and survival of pancreatic cancer patients.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
396633
Name
Landon-Brace Natalie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Probing T-Cell Response in a Hypoxic Pancreatic Tumour Microenvironment using TRACER
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Biomedical Engineering; Cancer; Drug Discovery Models; Hypoxia; Immunotherapy; Pancreatic Cancer; Rna Sequencing; Tissue Engineering; Tissue Mimetic In Vitro Platform; Tumour Microenvironment
Abstract
Pancreatic cancer is set to surpass breast cancer as the third leading cause of cancer deaths in Canada. Currently, only 7% of patients with pancreatic cancer will survive five years after diagnosis. The disease is often diagnosed too late for surgery, and it is generally resistant to chemotherapy and radiation. As such, new treatment options are desperately needed. Immunotherapy - treatments which recruit a patient's immune system to eliminate cancer cells - has been successful for some cancers but has fallen short in pancreatic cancer. This is partly because pancreatic cancer actively suppresses the immune system, preventing it from killing cancer cells. Investigating the interaction between the immune system and cancer cells using traditional 2D or living animal models has not yielded effective ways to solve this problem. Now, a 3D platform developed by our lab called "Tumour Roll for Analysis of Cellular Environment" - TRACER - is creating new opportunities to study these interactions.
TRACER is an engineered 3D tumour model. Cells are grown on a paper strip wrapped around a metal cylinder to create a tumour in a dish that is similar to what would be in a patient. Unlike in a patient, TRACER can be unrolled to look inside the tumour to examine cell interactions up-close. This allows us to understand why immune cells are not functioning properly. Using TRACER, we will create tumours using patients' cells to investigate cellular interactions and identify molecules in the environment that affect the immune system. We will then engineer immune cells to function in the tumour environment and kill cancer cells. In knowing which engineered cells are successful, we can highlight the gene and protein targets which may be important to enhancing immunotherapy in pancreatic cancer and pass these targets along to those developing new drugs. In doing so, we will potentially create treatments that improve the quality of life and survival of pancreatic cancer patients.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Landon-Brace, Natalie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~